| Menkes disease |
| Classification and external resources |
ATP7A |
| ICD-10 |
E83.0 |
| ICD-9 |
759.89 |
| ICD-O: |
? |
| OMIM |
309400 |
| DiseasesDB |
8029 |
| MedlinePlus |
001160 |
| eMedicine |
neuro/569 ped/1417 derm/715 |
| MeSH |
D007706 |
Menkes disease (MNK), also called Menkes syndrome, copper transport disease, steely hair disease, kinky hair disease, or Menkes kinky hair syndrome,[1][2] is a disorder that affects copper levels in the body,[3] leading to copper deficiency.[4] It is an x-linked recessive disorder, and is therefore considerably more common in males: females require two defective alleles to develop the disease.
The disorder was originally described by John Hans Menkes (1928–2008) et al. in 1962.[5]
|
Contents
- 1 Characteristics
- 2 Cause and Genetics
- 3 Diagnosis and Treatment
- 4 Epidemiology
- 5 See also
- 6 References
- 7 External links
|
Characteristics
Image shows the phenotypic appearance of the baby – the characteristics steel fuzzy sparse hair, fair complexion, The chubby cheeks, irritable baby
Microscopic examination of hair, revealing classical sign of
pili torti. From Datta et al., 2008.
MNK is characterized by sparse and coarse hair, growth failure, and deterioration of the nervous system. Onset of Menkes syndrome typically begins during infancy. Signs and symptoms of this disorder include weak muscle tone (hypotonia), sagging facial features, seizures, mental retardation, and developmental delay. The patients have brittle hair and metaphyseal widening. In rare cases, symptoms begin later in childhood and are less severe. Affected infants may be born prematurely. Symptoms appear during infancy and are largely a result of abnormal intestinal copper absorption with secondary deficiency in copper-dependent mitochondrial enzymes. Normal or slightly slowed development may proceed for 2 to 3 months, and then there will be severe developmental delay and a loss of early developmental skills. Menkes Disease is also characterized by seizures, failure to thrive, subnormal body temperature, and strikingly peculiar hair, which is kinky, colorless or steel-colored, and easily broken. There can be extensive neurodegeneration in the gray matter of the brain.[6] Arteries in the brain can also be twisted with frayed and split inner walls. This can lead to rupture or blockage of the arteries. Weakened bones (osteoporosis) may result in fractures.
Occipital horn syndrome (sometimes called X-linked cutis laxa or Ehlers-Danlos type 9[7]), is a mild form of Menkes syndrome that begins in early to middle childhood. It is characterized by calcium deposits in a bone at the base of the skull (occipital bone), coarse hair, and loose skin and joints.
Cause and Genetics
Mutations in the ATP7A gene, located on chromosome Xq21.1,[8] are the cause of Menkes syndrome.[9] This condition is inherited in an X-linked recessive pattern.[10] As the result of a mutation in the ATP7A gene, copper is poorly distributed to cells in the body. Copper accumulates in some tissues, such as the small intestine and kidneys, while the brain and other tissues have unusually low levels. The decreased supply of copper can reduce the activity of numerous copper-containing enzymes that are necessary for the structure and function of bone, skin, hair, blood vessels and the nervous system such as lysyl oxidase.
Diagnosis and Treatment
Urine homovanillic acid/vanillylmandelic acid ratio has been proposed as a screening tool to support earlier detection.[11] Early treatment with subcutaneous (under the skin) or intravenous (in a vein) injections of copper supplements (in the form of acetate salts) may be of some benefit.[12] Other treatment is symptomatic and supportive.
Epidemiology
One European study reported a rate of 1 in 254,000;[13] a Japanese study reported a rate of 1 in 357,143.[14]
See also
- Folliculitis decalvans
- List of cutaneous conditions
- Copper in health
- Hereditary copper metabolic diseases
- List of radiographic findings associated with cutaneous conditions
References
- ^ Online 'Mendelian Inheritance in Man' (OMIM) 309400
- ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. p. 765. ISBN 0-7216-2921-0.
- ^ "Menkes syndrome" at Dorland's Medical Dictionary
- ^ de Bie P, Muller P, Wijmenga C, Klomp LW (Nov 2007). "Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes" (Free full text). J. Med. Genet. 44 (11): 673–688. doi:10.1136/jmg.2007.052746. PMC 2752173. PMID 17717039. http://jmg.bmj.com/cgi/pmidlookup?view=long&pmid=17717039.
- ^ Menkes JH, Alter M, Steigleder GK, Weakley DR, Sung JH (1962). "A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration". Pediatrics 29: 764–779. PMID 14472668.
- ^ Barnes N, Tsivkovskii R, Tsivkovskaia N, Lutsenko S (2005). "The copper-transporting ATPases, menkes and wilson disease proteins, have distinct roles in adult and developing cerebellum". J Biol Chem 280 (10): 9640–5. doi:10.1074/jbc.M413840200. PMID 15634671.
- ^ http://emedicine.medscape.com/article/1180460-overview
- ^ Online 'Mendelian Inheritance in Man' (OMIM) 300011
- ^ Voskoboinik I, Camakaris J (2002). "Menkes copper-translocating P-type ATPase (ATPTA): biochemical and cell biology properties, and role in Menkes disease". J Bioenerg Biomembr 34 (5): 363–71. doi:10.1023/A:1021250003104. PMID 12539963.
- ^ Kim BE, Smith K, Meagher CK, Petris MJ (November 2002). "A conditional mutation affecting localization of the Menkes disease copper ATPase. Suppression by copper supplementation". J. Biol. Chem. 277 (46): 44079–84. doi:10.1074/jbc.M208737200. PMID 12221109. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=12221109.
- ^ Matsuo M, Tasaki R, Kodama H, Hamasaki Y (2005). "Screening for Menkes disease using the urine HVA/VMA ratio". J. Inherit. Metab. Dis. 28 (1): 89–93. doi:10.1007/s10545-005-5083-6. PMID 15702409.
- ^ Kaler SG, Holmes CS, Goldstein DS, et al. (February 2008). "Neonatal diagnosis and treatment of Menkes disease". N. Engl. J. Med. 358 (6): 605–14. doi:10.1056/NEJMoa070613. PMID 18256395. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=18256395&promo=ONFLNS19.
- ^ Tønnesen T, Kleijer WJ, Horn N (February 1991). "Incidence of Menkes disease". Hum. Genet. 86 (4): 408–10. doi:10.1007/BF00201846. PMID 1999344.
- ^ Gu YH, Kodama H, Shiga K, Nakata S, Yanagawa Y, Ozawa H (2005). "A survey of Japanese patients with Menkes disease from 1990 to 2003: incidence and early signs before typical symptomatic onset, pointing the way to earlier diagnosis". J. Inherit. Metab. Dis. 28 (4): 473–8. doi:10.1007/s10545-005-0473-3. PMID 15902550.
External links
- GeneReviews/NCBI/NIH/UW entry on ATP7A-Related Copper Transport Disorders
- Media related to menkes disease at Wikimedia Commons
|
Inborn error of metal metabolism (E83, 275)
|
|
| Transition metal |
|
Fe
|
high: Primary iron overload disorder: Hemochromatosis/HFE1 · Juvenile/HFE2 · HFE3 · African iron overload/HFE4 · Aceruloplasminemia · Atransferrinemia · Hemosiderosis
deficiency: Iron deficiency
|
|
|
Cu
|
high: Copper toxicity · Wilson's disease
deficiency: Copper deficiency · Menkes disease/Occipital horn syndrome
|
|
|
Zn
|
high: Zinc toxicity
deficiency: Acrodermatitis enteropathica
|
|
|
| Electrolyte |
|
Na+ and K+
|
see Template:Water-electrolyte imbalance and acid-base imbalance
|
|
|
PO43−
|
high: Hyperphosphatemia
deficiency: Hypophosphatemia · alkaline phosphatase (Hypophosphatasia)
|
|
|
Mg2+
|
high: Hypermagnesemia
deficiency: Hypomagnesemia
|
|
|
Ca2+
|
high: Hypercalcaemia · Milk-alkali syndrome (Burnett's) · Calcinosis (Calciphylaxis, Calcinosis cutis) · Calcification (Metastatic calcification, Dystrophic calcification) · Familial hypocalciuric hypercalcemia
deficiency: Hypocalcaemia · Osteomalacia · Pseudohypoparathyroidism (Albright's hereditary osteodystrophy) · Pseudopseudohypoparathyroidism
|
|
|
|
|
|
noco, nuvi, sysi/epon, met
|
|
|
|
|
|
Sex linkage: X-linked disorders
|
|
|
X-linked recessive
|
|
| Immune |
- Chronic granulomatous disease (CYBB)
- Wiskott–Aldrich syndrome
- X-linked severe combined immunodeficiency
- X-linked agammaglobulinemia
- Hyper-IgM syndrome type 1
- IPEX
- X-linked lymphoproliferative disease
- Properdin deficiency
|
|
| Hematologic |
- Haemophilia A
- Haemophilia B
- X-linked sideroblastic anemia
|
|
| Endocrine |
- Androgen insensitivity syndrome/Kennedy disease
- KAL1 Kallmann syndrome
- X-linked adrenal hypoplasia congenita
|
|
| Metabolic |
- amino acid: Ornithine transcarbamylase deficiency
- Oculocerebrorenal syndrome
- dyslipidemia: Adrenoleukodystrophy
- carbohydrate metabolism: Glucose-6-phosphate dehydrogenase deficiency
- Pyruvate dehydrogenase deficiency
- Danon disease/glycogen storage disease Type IIb
- lipid storage disorder: Fabry's disease
- mucopolysaccharidosis: Hunter syndrome
- purine-pyrimidine metabolism: Lesch–Nyhan syndrome
- mineral: Menkes disease/Occipital horn syndrome
|
|
| Nervous system |
- X-linked mental retardation: Coffin–Lowry syndrome
- MASA syndrome
- X-linked alpha thalassemia mental retardation syndrome
- Siderius X-linked mental retardation syndrome
- eye disorders: Color blindness (red and green, but not blue)
- Ocular albinism (1)
- Norrie disease
- Choroideremia
- other: Charcot–Marie–Tooth disease (CMTX2-3)
- Pelizaeus–Merzbacher disease
- SMAX2
|
|
| Skin and related tissue |
- Dyskeratosis congenita
- Hypohidrotic ectodermal dysplasia (EDA)
- X-linked ichthyosis
- X-linked endothelial corneal dystrophy
|
|
| Neuromuscular |
- Becker's muscular dystrophy/Duchenne
- Centronuclear myopathy (MTM1)
- Conradi–Hünermann syndrome
- Emery–Dreifuss muscular dystrophy 1
|
|
| Urologic |
- Alport syndrome
- Dent's disease
- X-linked nephrogenic diabetes insipidus
|
|
| Bone/tooth |
- AMELX Amelogenesis imperfecta
|
|
| No primary system |
- Barth syndrome
- McLeod syndrome
- Smith–Fineman–Myers syndrome
- Simpson–Golabi–Behmel syndrome
- Mohr–Tranebjærg syndrome
- Nasodigitoacoustic syndrome
|
|
|
|
X-linked dominant
|
|
- X-linked hypophosphatemia
- Focal dermal hypoplasia
- Fragile X syndrome
- Aicardi syndrome
- Incontinentia pigmenti
- Rett syndrome
- CHILD syndrome
- Lujan–Fryns syndrome
- Orofaciodigital syndrome 1
- Craniofrontonasal dysplasia
|
|
|
|
Genetic disorder, membrane: ATPase disorders
|
|
| ATP1 |
- ATP1A2 (Alternating hemiplegia of childhood)
|
|
| ATP2 |
- ATP2A1 (Brody myopathy)
- ATP2A2 (Darier's disease, Acrokeratosis verruciformis)
- ATP2C1 (Hailey–Hailey disease)
|
|
| ATP7 |
- ATP7A (Menkes disease)
- ATP7B (Wilson's disease)
|
|
| ATP13 |
- ATP13A2 (Kufor–Rakeb syndrome)
|
|
| Other |
|
|
see also ATPase
- B structural
- perx
- skel
- cili
- mito
- nucl
- sclr
- DNA/RNA/protein synthesis
- membrane
- transduction
- trfk
|
|
